The Dilated Cardiomyopathy Puzzle: A Mitochondrial Defect
A 34-year-old woman presents with fatigue, shortness of breath, and palpitations. Echocardiography shows a dilated left ventricle with an ejection fraction of 30% (normal >55%). Family history reveals that her mother and maternal uncle died suddenly in their 40s. Genetic testing identifies a heteroplasmic mutation in the mitochondrial gene MT-TL1 (m.3243A>G), which encodes a mitochondrial tRNA for leucine. Muscle biopsy shows ragged red fibers and reduced cytochrome c oxidase staining. The mutation load in blood is 30%, in skeletal muscle 70%, and in cardiac muscle 85%. Her brother is asymptomatic with a mutation load of 10% in blood. The patient asks about the risk to her children and whether the mutation explains her heart failure.
1. Explain how the heteroplasmic mutation in MT-TL1 could lead to dilated cardiomyopathy. Include the role of oxidative phosphorylation and the threshold effect.
Read the worked answer
The MT-TL1 gene encodes a mitochondrial tRNA necessary for translating the 13 proteins encoded by mtDNA, all of which are subunits of the electron transport chain (ETC). A mutation impairs mitochondrial protein synthesis, reducing the assembly and activity of ETC complexes, particularly complexes I and IV. This decreases oxidative phosphorylation and ATP production. Cardiac muscle has high energy demand; when the proportion of mutant mtDNA exceeds a threshold (often ~60-80% in affected tissues), ATP supply falls below the demand, leading to impaired contractility, myocyte damage, and compensatory dilation. The threshold effect explains why tissues with high mutation loads (heart 85%, muscle 70%) are affected while blood (30%) is not. The resulting energy deficit activates stress pathways, fibrosis, and apoptosis, contributing to dilated cardiomyopathy.
2. What is the risk that her children will inherit the mutation? Consider the heteroplasmic nature and the bottleneck in oogenesis.
Read the worked answer
Mitochondrial DNA is inherited exclusively from the mother. During oogenesis, a bottleneck reduces the number of mtDNA molecules passed to each oocyte, so the mutation load in children can vary widely (from very low to very high). The mother's blood mutation load (30%) is not directly predictive of the load in her oocytes. Each child has a risk of inheriting a mutation load that could range from near 0% to over 80%, depending on which oocytes are fertilized. Thus, some children may be asymptomatic carriers (like her brother with 10%), while others could be severely affected if the load exceeds the threshold in critical tissues. Genetic counseling should explain this uncertainty and the possibility of prenatal or preimplantation testing, though interpretation is complicated by tissue-specific loads.